Health Condition 1: I20- Angina pectoris Health Condition 2: I504- Combined systolic (congestive) anddiastolic (congestive) heart failure Health Condition 3: I501- Left ventricular failure, unspecified Health Condition 4: I21A- Other type of myocardial infarction Health Condition 5: I502- Systolic (congestive) heart failure
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Those had undergone: 1.Cardiac events- myocardial infarction, coronary artery disease, stable angina, heart failure. 2.Interventions-Coronary Artery Bypass Grafting, Percutaneous Coronary Interventions, Valve Replacement, Pacemaker, Implanted Cardioverter Defibrillator. 3.Are in class-I and II according to New York Heart Association Functional Classification of Heart Failure.
Exclusion criteria
Exclusion criteria: 1.Those had Unstable angina pectoris,Acute endomyocarditis or other acute infections, Recent pulmonary artery embolism or phlebothrombosis, hemodynamically relevant arrhythmia, Critical obstructions of the left ventricular discharge apparatus 2. Those who have Physical, psychological or mental limitations prohibiting cardiac rehabilitation 3. Those who are in class-III and IV according to New York Heart Association Functional Classification of Heart Failure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Proportion of patients with improved physical activity i.e. at least 30 minutes of moderate physical activity 5 days a week or more (minimum 150 minutes /week) 2.Proportion of patients with improved Diet i.e Saturated fats: 10% of total dietary energy per day, Fruits and vegetable: at least five portions of fruits and vegetable in a day or 400gms per day, Salt intake: less than 6gms of salt per day. 3.Medication Adherence Timepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.6-Minute walk distance 2.BMI ( 25kg/m2) 3.Blood Pressure (140/90 mmHg) 4.Lipid Profile: Total Cholesterol (5·0 mmol/L), Triglycerides (150mg/dL), LDL (Low Density Lipids) (129mg/dL), HDL (High Density Lipids) (60mg/dL). 5.HRQOL (Health related quality of life) 6.Depression 7.Anxiety Long term outcomes: will be assessed after 6 months in terms of- 1.Re-hospitalization 2.Survival Timepoint: 3 months | — |
Countries
India
Contacts
UCG and Govt of India